CompletedPhase 3Phase 4ACTRN12605000640606
Milrinone for Free Flap Surgery
Milrinone versus placebo infusion intraoperatively to prevent vasospasm during free flap surgery
Sponsor
Department of Anaesthesia, St Vincent's Hospital Melbourne
Enrollment
100 participants
Start Date
May 1, 2002
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Inclusion Criteria1
- Elective patients for free flap surgery.Serious cardiac disease, stenotic or ischaemic cardiac disease and history of ventricular arrhythmias.Previous adverse reaction or allergy to milrinone.Renal impairment Cr > 0.15 mmol/L.
Exclusion Criteria1
- Inability to give informed consent and patient refusal.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Double-blind, randomised control trial comparing free flap surgery outcomes after intra-operative Milrinone or placebo at 0.25ug/kg/min infusion during anaesthesia with a 25ug/kg bolus over 20 minutes
Double-blind, randomised control trial comparing free flap surgery outcomes after intra-operative Milrinone or placebo at 0.25ug/kg/min infusion during anaesthesia with a 25ug/kg bolus over 20 minutes after induction of anaesthesia.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000640606